<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56975">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01845233</url>
  </required_header>
  <id_info>
    <org_study_id>2012/1142(REK)</org_study_id>
    <nct_id>NCT01845233</nct_id>
  </id_info>
  <brief_title>Monitoring of Non-invasive Ventilation</brief_title>
  <official_title>Monitoring of Non-invasive Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Trondheim University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <authority>Norway: Norwegian Medicines Agency</authority>
    <authority>Norway: Norwegian Social Science Data Services</authority>
    <authority>Norway: Directorate of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether clinical examination, report from
      ventilator software, nocturnal Sp02 and daytime arterial blood gas are sufficient as
      screening tools to reveal clinical relevant problems with patients receiving long term
      treatment with non invasive ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient with chronic hypoventilation with stable on long term treatment (LTMV) with
      non-invasive ventilation for at least 3 month taking part of our LTMV program will be
      included.

      In addition to clinical examination,report from ventilator software, nocturnal Sp02 and
      daytime arterial blood gas all patients will be investigated with sleep polygraphy and
      transcutaneous Co2.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Frequency of transcutaneous co2 revealing sleep hypoventilation, when nocturnal pulseoximeter is normal</measure>
    <time_frame>single night study</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of patient-ventilator asynchrony during non invasive ventilation ?</measure>
    <time_frame>Single night study</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Technical drift of Transcutaneous Co2 measurement during 8 hours monitoring</measure>
    <time_frame>One night study</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Interscorer variability when scoring polygraphy during Non invasive ventilation</measure>
    <time_frame>one night study</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Comparing rate of event data from ventilator software  with manually scored  polygraphy during non invasive ventilation</measure>
    <time_frame>Single night study</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Accuracy of Transcutaneous monitoring of Co2 compared to arterial carbon dioxide partial pressure</measure>
    <time_frame>single night study</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Frequency of sleep related breathing events during non invasive ventilation</measure>
    <time_frame>single night study</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hypoventilation</condition>
  <arm_group>
    <arm_group_label>Non invasive ventilation</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic hypoventilation treated with long term mechanical ventilation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Admitted to our unit for optimal treatment of long term non invasive ventilation

          -  Readmitted for control after 6-8 weeks

          -  Then treated for at least 3 month with long term non invasive ventilation outside of
             hospital.

          -  Informed written consent

        Exclusion Criteria:

          -  Under 18 years old

          -  Lack of cooperation

          -  Pregnant

          -  Acute exacerbation  last 3 month leading to hospital admission.

          -  Change of treatment last 3 month
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sigurd aarrestad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sigurd Aarrestad, MD</last_name>
    <phone>+4790073302</phone>
    <email>sigurd.aarrestad@oslo-universitetssykehus.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ole Skj√∏nsberg, Professor</last_name>
    <phone>+4722118080</phone>
    <email>o.h.skjonsberg@medisin.uio.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0471</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sigurd Aarrestad, MD</last_name>
      <phone>+4790073302</phone>
      <email>sigurd.aarrestad@oslo-universitetssykehus.no</email>
    </contact>
    <investigator>
      <last_name>Sigurd Aarrestad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>May 1, 2013</lastchanged_date>
  <firstreceived_date>March 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
